(Reuters) -The world’s largest dialysis specialist Fresenius Medical Care said, ahead of its capital markets day on Tuesday, that it plans to embark on a 1 billion euros ($1.16 billion) share buyback programme.
The dialysis provider for 300,000 patients worldwide said it plans to start the programme in the second half of the year.
($1 = 0.8650 euros)
(Reporting by Tristan Veyet in Gdansk, editing by xxx)
